Bone Cancer Clinical Trials

• HLA Sensitization Following Major Cortical Allograft Bone Procedures
  ClinicalTrials.gov Identifier: NCT00160719 - Recruiting
  Bone Cancer
  
• Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-Induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00172055 - Recruiting
  Cancer Prostate
  
• Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases
  ClinicalTrials.gov Identifier: NCT00002503 - Active, not recruiting
  bone metastases; recurrent prostate cancer
  
• Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00005804 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma; Eye Cancer
  
• Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
  ClinicalTrials.gov Identifier: NCT00007813 - Active, not recruiting
  childhood liver cancer; Bone Cancer; Testicular Cancer; Brain Tumor
  
• Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00079001 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer; bone metastases
  
• Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98
  ClinicalTrials.gov Identifier: NCT00369850 - Active, not recruiting
  Breast Cancer; Osteoporosis
  
• Open-label Trial on the Effect of I.V. Zometa 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients with Bone Metastasis
  ClinicalTrials.gov Identifier: NCT00035997 - Active, not recruiting
  Prostate Cancer
  
• Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00081159 - Active, not recruiting
  recurrent prostate cancer; stage IV prostate cancer; bone metastases
  
• Safety & Efficacy of Toremifene Citrate for Prevention of Bone Fractures in Men with Prostate Cancer on Androgen Deprivation Therapy
  ClinicalTrials.gov Identifier: NCT00129142 - Active, not recruiting
  Prostate Cancer; Osteoporosis; Bone Loss; Fractures
  
• High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors
  ClinicalTrials.gov Identifier: NCT00060255 - Active, not recruiting
  Cancer
  
• Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00080782 - Active, not recruiting
  recurrent prostate cancer; stage IV prostate cancer; bone metastases
  
• Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
  ClinicalTrials.gov Identifier: NCT00365105 - Recruiting
  Breast Cancer; Lung Cancer; Metastatic Cancer; Pain; Prostate Cancer
  
• Assessment of the Efficacy, Tolerability and Pharmaco-Economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis
  ClinicalTrials.gov Identifier: NCT00241111 - Active, not recruiting
  Prostate Cancer With Bone Metastasis
  
• Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00181584 - Active, not recruiting
  Bone Loss; Prostate Cancer
  
• Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation
  ClinicalTrials.gov Identifier: NCT00264420 - Recruiting
  Bone Metastases; Breast Cancer; Lung Cancer; Prostate Cancer
  
• Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00080678 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer; bone metastases
  
• High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation and Chemoprotective Therapy in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00003425 - Active, not recruiting
  Leukemia; Bone Cancer; ovarian sarcoma; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma
  
• Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00199537 - Active, not recruiting
  Prostate Cancer; Bone Loss
  
• Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer
  ClinicalTrials.gov Identifier: NCT00334139 - Recruiting
  Prostate Cancer; Breast Cancer; Bone Metastasis
  
• Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00060138 - Active, not recruiting
  Hypercalcemia; stage IV breast cancer; recurrent breast cancer; bone metastases; Pain
  
• Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer
  ClinicalTrials.gov Identifier: NCT00003657 - Active, not recruiting
  Lung Cancer; Gastrointestinal Cancer; Reproductive Cancers; Head and Neck Cancer; Bone Cancer; Kaposi's Sarcoma; Soft Tissue Sarcoma
  
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Previously Untreated Germ Cell Cancer
  ClinicalTrials.gov Identifier: NCT00003941 - Active, not recruiting
  bone metastases; brain metastases; liver metastases; Mediastinal Cancer; Testicular Cancer
  
• Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003903 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; Osteoporosis
  
• Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00008203 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; stage II breast cancer
  
• A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)
  ClinicalTrials.gov Identifier: NCT00399802 - Active, not recruiting
  Breast Cancer; Metastatic Bone Disease
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma
  ClinicalTrials.gov Identifier: NCT00002601 - Active, not recruiting
  Bone Cancer; Soft Tissue Sarcoma
  
• High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003173 - Active, not recruiting
  Testicular Cancer; Brain Tumor; Eye Cancer
  
• Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00002566 - Active, not recruiting
  recurrent testicular cancer; extragonadal germ cell tumor
  
• Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplantation Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00011921 - Active, not recruiting
  limited stage small cell lung cancer; extensive stage small cell lung cancer
  
• Adjuvant Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00072020 - Active, not recruiting
  bone metastases; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
  ClinicalTrials.gov Identifier: NCT00392938 - Recruiting
  Metastatic Cancer; Prostate Cancer
  
• Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00391690 - Recruiting
  Prostate Cancer
  
• A Study to Evaluate Pregabalin in the Treatment of Moderate to Severe Chronic Bone Pain Related to Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00381095 - Recruiting
  Bone Neoplasms; Pain, Intractable; Cancer
  
• Physical Characteristics of Retrieved Massive Allografts
  ClinicalTrials.gov Identifier: NCT00160758 - Recruiting
  Bone Cancer
  
• Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions
  ClinicalTrials.gov Identifier: NCT00375427 - Recruiting
  Breast Cancer With Bone Metastasis
  
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00012181 - Active, not recruiting
  childhood bone cancer; childhood brain cancer; childhood eye cancer; childhood kidney tumors; childhood non-Hodgkin's lymphoma; ...
  
• Zometa and Circulating VEGF in Breast Cancer Patients With Bone Metastasis
  ClinicalTrials.gov Identifier: NCT00524849 - Recruiting
  Metastatic Breast Cancer; Bone Metastases
  
• The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)
  ClinicalTrials.gov Identifier: NCT00436059 - Recruiting
  Multiple Myeloma
  
• Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00073879 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Bone Mineral Density and Subsequent Cancer Risk
  ClinicalTrials.gov Identifier: NCT00340262 - Active, not recruiting
  Bone Mineral Density; Cancer
  
• Bone Response in Metastatic Breast Cancer Involving Bones
  ClinicalTrials.gov Identifier: NCT00420433 - Recruiting
  Breast Cancer; Bone Metastases
  
• Comparing Synthetic Bone Alone Versus Synthetic Bone with Bone Marrow in Bone Lesions
  ClinicalTrials.gov Identifier: NCT00147823 - Recruiting
  Benign bone lesion
  
• ZD4054 in Treating Patients With Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00107146 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer; bone metastases
  
• Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
  ClinicalTrials.gov Identifier: NCT00003884 - Active, not recruiting
  Pain; bone metastases; Recurrent Small Cell Lung Cancer; unspecified adult solid tumor, protocol specific; recurrent non-small cell lung cancer; ...
  
• Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003162 - Active, not recruiting
  Pain; stage IV prostate cancer; stage IV breast cancer; recurrent breast cancer; bone metastases; recurrent prostate cancer
  
• Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003926 - Active, not recruiting
  childhood soft tissue sarcoma; childhood liver cancer; adult soft tissue sarcoma; Bone Cancer; ovarian sarcoma; Testicular Cancer; Brain Tumor; ...
  
• Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
  ClinicalTrials.gov Identifier: NCT00429507 - Recruiting
  Breast Cancer; Bone Metastases
  
• Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy
  ClinicalTrials.gov Identifier: NCT00485953 - Recruiting
  Bone Loss; Osteoporosis; Breast Cancer
  
• A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00399321 - Recruiting
  Postmenopausal Bone Loss; Breast Cancer
  
• A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.
  ClinicalTrials.gov Identifier: NCT00478270 - Recruiting
  Pain;; Bone Neoplasms;; Neoplasm Metastasis
  
• A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.
  ClinicalTrials.gov Identifier: NCT00502736 - Recruiting
  Pain;; Bone Neoplasms;; Neoplasm Metastasis
  
• A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00156884 - Recruiting
  Hormone Refractory Prostate Cancer; Bone Metastases
  
• Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00489905 - Recruiting
  Prostatic Neoplasms; Bone Density
  
• Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00134056 - Recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer; bone metastases
  
• Double-Blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Subjects With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00330759 - Recruiting
  Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
  
• A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00445731 - Active, not recruiting
  Cancer
  
• A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
  ClinicalTrials.gov Identifier: NCT00321464 - Recruiting
  Bone Metastases in Subjects With Advanced Breast Cancer
  
• Combination Chemotherapy Followed by Donor Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Genetic Disorders
  ClinicalTrials.gov Identifier: NCT00008307 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; plasma cell neoplasm
  
• Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS
  ClinicalTrials.gov Identifier: NCT00324714 - Recruiting
  Breast Cancer; Osteoporosis
  
• Repeated Bone Marrow Transplantation in Treating Patients With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003086 - Active, not recruiting
  stage IV breast cancer
  
• Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Aplastic Anemia or Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003816 - Recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer
  
• Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00019695 - Active, not recruiting
  Stage IV Prostate Cancer; Bone Metastases; Adenocarcinoma of the Prostate; Recurrent Prostate Cancer
  
• Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00005988 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Donor Bone Marrow Transplant in Treating Young Patients with Cancer Or a Non-Cancerous Disease
  ClinicalTrials.gov Identifier: NCT00118326 - Active, not recruiting
  Wilms'' tumor and other childhood kidney tumors; childhood Hodgkin''s lymphoma; childhood non-Hodgkin''s lymphoma; childhood rhabdomyosarcoma; Leukemia; ...
  
• High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00002854 - Active, not recruiting
  Breast Cancer; Gastrointestinal Cancer; Kidney Cancer; Musculoskeletal Cancer; Reproductive Cancer; Skin Cancer
  
• Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00006042 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ...
  
• Treatment with Zometa in patients with breast cancer, multiple myeloma, and prostate cancer with cancer related bone lesions
  ClinicalTrials.gov Identifier: NCT00029224 - Active, not recruiting
  Breast Cancer; Multiple Myeloma; Prostate Cancer
  
• Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00202059 - Active, not recruiting
  Breast Cancer
  
• The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
  ClinicalTrials.gov Identifier: NCT00063609 - Active, not recruiting
  Prostate Cancer
  
• ZD4054 in Pain-free or Mildly Symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA)
  ClinicalTrials.gov Identifier: NCT00090363 - Active, not recruiting
  Prostate Cancer
  
• A Placebo-Controlled Phase II Study of Bone-Targeted Radium-223 in Symptomatic Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00459654 - Active, not recruiting
  Prostate Cancer; Neoplasm Metastasis
  
• Radiation Therapy and Fludarabine Followed by Donor Peripheral Stem Cell Transplantation, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00014235 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer
  
• Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003060 - Active, not recruiting
  Recurrent Melanoma
  
• Double-Blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Men With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00321620 - Recruiting
  Bone Metastases in Men With Hormone-Refractory Prostate Cancer
  
• Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002658 - Active, not recruiting
  Myeloid Leukemia; Neutropenia
  
• Risedronate Sodium on Bone in Postmenopausal Women with Hormone-Receptor-Positive Early Breast Cancer
  ClinicalTrials.gov Identifier: NCT00082277 - Active, not recruiting
  Breast Cancer
  
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00014469 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; Graft Versus Host Disease; myelodysplastic and myeloproliferative disease
  
• Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
  ClinicalTrials.gov Identifier: NCT00054418 - Active, not recruiting
  Osteoporosis; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
  
• AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00089674 - Active, not recruiting
  Prostate Cancer
  
• Allogeneic Stem Cell Transplantation in Treating Patients With Metastatic Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00056095 - Recruiting
  recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004092 - Recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
  
• Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003815 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Total-Body Irradiation Plus Chemotherapy Followed By Donor Bone Marrow Transplantation in Treating Children With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00028730 - Active, not recruiting
  acute leukemia; childhood large cell lymphoma; childhood lymphoblastic lymphoma; childhood small noncleaved cell lymphoma; chronic leukemia; ...
  
• Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-Related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy
  ClinicalTrials.gov Identifier: NCT00237146 - Active, not recruiting
  Prostate Cancer
  
• Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone
  ClinicalTrials.gov Identifier: NCT00181558 - Active, not recruiting
  Prostate Cancer; Adenocarcinoma of the Prostate
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer
  ClinicalTrials.gov Identifier: NCT00002931 - Recruiting
  extragonadal germ cell tumor; ovarian germ cell tumor; Testicular Cancer
  
• Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause
  ClinicalTrials.gov Identifier: NCT00290212 - Active, not recruiting
  Bone Density; Menopause
  
• Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination
  ClinicalTrials.gov Identifier: NCT00143780 - Active, not recruiting
  Bone Marrow Transplant
  
• Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
  ClinicalTrials.gov Identifier: NCT00302627 - Active, not recruiting
  Transplant Bone Disease
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer
  ClinicalTrials.gov Identifier: NCT00025558 - Active, not recruiting
  adult brain tumor; childhood central nervous system germ cell tumor; childhood ependymoma; Childhood Medulloblastoma; ...
  
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002701 - Active, not recruiting
  untreated adult acute myeloid leukemia; adult acute promyelocytic leukemia (M3)
  
• Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00049452 - Active, not recruiting
  Osteoporosis; stage I breast cancer; stage II breast cancer
  
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
  ClinicalTrials.gov Identifier: NCT00002515 - Completed
  bone marrow ablation; Cancer
  
• MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease
  ClinicalTrials.gov Identifier: NCT00302471 - Active, not recruiting
  Prostatic Neoplasms
  
• Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003854 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00024037 - Active, not recruiting
  oral complications of cancer and cancer therapy
  
• Safety and Efficacy Trial with Zoledronic Acid for the Treatment of Paget's Disease of Bone
  ClinicalTrials.gov Identifier: NCT00103740 - Active, not recruiting
  Paget's Disease of Bone
  
• Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00004006 - Active, not recruiting
  extraocular retinoblastoma; recurrent retinoblastoma; intraocular retinoblastoma
  
• Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00063817 - Active, not recruiting
  Kidney Failure; Bone Marrow Transplantation; Kidney Transplantation; Kidney Failure, Chronic